Literature DB >> 28214859

Farnesoid X Receptor in Mice Prevents Severe Liver Immunopathology During Lymphocytic Choriomeningitis Virus Infection.

Nadine Honke, Namir Shaabani, Cornelia Hardt, Caroline Krings, Dieter Häussinger, Philipp A Lang, Karl S Lang, Verena Keitel.   

Abstract

BACKGROUND: Bile acids (BAs) are steroid molecules that are synthesized in the liver. In addition to their important role as a surfactant in solubilizing lipids and promoting the absorption of lipids in the gastrointestinal tract, they act as inflammagens. The role of BAs and their receptor farnesoid X receptor (FXR) during viral infection has not been studied in detail.
METHODS: By using FXR-deficient mice, we investigated the role of bile acid receptor FXR during infection with lymphocytic choriomeningitis virus (LCMV). The importance of FXR in inducing IFN-I and monocytes proliferation were investigated and viral titers and T cell exhaustion were analyzed at different time points.
RESULTS: This study shows that controlled levels of BAs activate FXR in hepatocytes and FXR in response upregulates the production of type I interferon. In turn, FXR maintains BAs within a balanced range to inhibit their toxic effects. The absence of FXR results in high levels of BAs, which inhibit the proliferation of monocytes and result in a defect in viral elimination, consequently leading to T cell exhaustion.
CONCLUSION: We found that FXR contributes to IFN-I production in hepatocytes and balances BA levels to inhibit their toxic effects on monocytes.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Bile acids; FXR; IFN-I; LCMV; Monocytes; NR1H4

Mesh:

Substances:

Year:  2017        PMID: 28214859     DOI: 10.1159/000456168

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

1.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

2.  Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation.

Authors:  Ta-Chiang Liu; Justin T Kern; Umang Jain; Naomi M Sonnek; Shanshan Xiong; Katherine F Simpson; Kelli L VanDussen; Emma S Winkler; Talin Haritunians; Atika Malique; Qiuhe Lu; Yo Sasaki; Chad Storer; Michael S Diamond; Richard D Head; Dermot P B McGovern; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2021-05-18       Impact factor: 31.316

3.  Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.

Authors:  Qiong Jia; Lu Zhang; Jindong Zhang; Fei Pei; Shiwei Zhu; Qinghua Sun; Liping Duan
Journal:  Biomed Res Int       Date:  2019-04-03       Impact factor: 3.411

Review 4.  Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.

Authors:  Drishti Tiwari; Pawan Gupta
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

Review 5.  Microbiota regulation of viral infections through interferon signaling.

Authors:  Nurul I Wirusanti; Megan T Baldridge; Vanessa C Harris
Journal:  Trends Microbiol       Date:  2022-02-06       Impact factor: 18.230

Review 6.  The influence of microbiota-derived metabolites on viral infections.

Authors:  Ajisha Alwin; Stephanie M Karst
Journal:  Curr Opin Virol       Date:  2021-06-16       Impact factor: 7.121

7.  Protection by the Total Flavonoids from Rosa laevigata Michx Fruit against Lipopolysaccharide-Induced Liver Injury in Mice via Modulation of FXR Signaling.

Authors:  Lile Dong; Xu Han; Xufeng Tao; Lina Xu; Youwei Xu; Linlin Fang; Lianhong Yin; Yan Qi; Hua Li; Jinyong Peng
Journal:  Foods       Date:  2018-06-08

8.  Fexaramine as an entry blocker for feline caliciviruses.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  Antiviral Res       Date:  2018-02-15       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.